21st Century Business Herald reporter Xu Qiulian Shanghai report
In order to better understand the development status, scientific and technological achievements, listing guidance process of companies to be listed on the Science and Technology Innovation Board, 21st Century Business Herald jointly created the "Chuangxing Future 100" enterprise database and updated on schedule.
The 4th issue of the survey record
research purpose
"Chuangxing Future 100" enterprise library aims to sort out the development situation of all aspects of the company through field research and dialogue with corporate executives, and explore the most scientific and technological potential enterprises in the Yangtze River Delta region.
Survey time
May 13, 2022
Research object
Silic Yi Technology (Shanghai) Co., Ltd. (hereinafter referred to as "Silic Yi Technology")
Interviewer: Founder and Chairman of Silicic Yi Technology Tang Xueming
Company Profile
Silic Yi Technology was founded on October 11, 2017. It is a leading enterprise in the innovative application of RNA technology in China. It is a Shanghai high-tech enterprise with nucleic acid technology, synthetic biology technology and nanomaterial technology as the underlying technology. It mainly researches RNA nanobiological preparations, creates new green prevention and control products for agricultural, medical and civil use, and provides solutions for the field of whole health (One-Health).
Main business and products
At present, Siyi Technology has established a product pipeline such as sterilization, insecticide, and herbicide. The research and development of new RNA biopesticides will provide technical support for my country's national goals of food security, ecological security construction, and green and healthy development. At the same time, the company produces key enzymes and nucleotides for the various synthetic RNAs, which can also provide intermediate raw material services for the biomedical field.
patent and qualification certificate
As China's first high-tech enterprise for RNA nucleic acid biopesticides, Siyi Technology has built a key target gene library for more than 100 diseases and pests, and established a series of key technologies and industrialization platforms with independent intellectual property rights from research and development to production. It has built nearly 5,000 square meters of various functional areas in Zhangjiang, Shanghai. In 2021, it passed the National Pesticide Standardization Committee to obtain the first four RNA biopesticides - "nucleic acid interferon" naming letters issued by China. The first international tobacco mosaic virus nucleic acid interferon developed by the company has officially entered the field test of the national authoritative institution.
core technology application scenarios
At present, the products developed by the company are used in agricultural pre-production, during-production and post-production green prevention and control, and the future trend is to be combined with digitalization. Combined with outbreak data such as arable land pests and diseases, we will train modern farmers to upgrade to industrial workers through digital channels.
industry market size
Based on the current mass industry on the pipeline as an example, the company is estimated to have a market of about 10 billion US dollars worldwide. The global market occupies about US$66 billion in the field of direct pest control technology.
Financing history, valuation and listing plan
December 12, 2017, Angel Round, Yimi Enterprise Management (Shanghai) Partnership (Limited Partnership)
May 25, 2020, A, Qingkong Jinxin Capital, Tutai Asset
For more content, please download 21 Finance APP
